norgestrel has been researched along with Osteoporosis, Postmenopausal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eleftheriou, K; Haddad, F; Hawe, E; Humphries, SE; James, L; Montgomery, H; Onambele, G; Skelton, D; Woledge, R; Woods, D | 1 |
| Arrenbrecht, S; Caubel, P; Felsenberg, D; Garnero, P | 1 |
| Sobel, NB | 1 |
| Ellerington, MC; Hillard, TC; Lees, B; Stevenson, JC; Whitcroft, SI; Whitehead, MI | 1 |
| Arlot, ME; Bradbeer, JN; Meunier, PJ; Reeve, J | 1 |
| Welti, HJ | 1 |
2 review(s) available for norgestrel and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?
Topics: Breast Neoplasms; Cardiovascular Diseases; Desogestrel; Endometrium; Estrogen Replacement Therapy; Female; Humans; Norgestrel; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners; Risk Factors; Structure-Activity Relationship | 1994 |
[Prevention of secondary manifestations of menopause. Perspectives and alternatives].
Topics: Climacteric; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norgestrel; Osteoporosis, Postmenopausal | 1989 |
3 trial(s) available for norgestrel and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
IL-6-174G/C genotype is associated with the bone mineral density response to oestrogen replacement therapy in post-menopausal women.
Topics: Bone Density; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Interleukin-6; Norgestrel; Osteoporosis, Postmenopausal; Postmenopause; Treatment Outcome; United Kingdom | 2004 |
The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
Topics: Aged; Body Mass Index; Bone and Bones; Bone Density; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Estradiol; Female; Humans; Middle Aged; Norgestrel; Osteoporosis, Postmenopausal; Patient Dropouts; Patient Selection; Treatment Outcome | 2004 |
Postmenopausal bone loss: does HRT always work?
Topics: Administration, Cutaneous; Administration, Oral; Alkaline Phosphatase; Bone Density; Calcium; Creatinine; Estradiol; Estrogen Replacement Therapy; Female; Humans; Hydroxyproline; Longitudinal Studies; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Osteoporosis, Postmenopausal; Phosphates; Progesterone Congeners | 1993 |
1 other study(ies) available for norgestrel and Osteoporosis, Postmenopausal
| Article | Year |
|---|---|
Treatment of osteoporosis with parathyroid peptide (hPTH 1-34) and oestrogen: increase in volumetric density of iliac cancellous bone may depend on reduced trabecular spacing as well as increased thickness of packets of newly formed bone.
Topics: Aged; Bone and Bones; Bone Density; Estrogen Replacement Therapy; Female; Humans; Middle Aged; Norgestrel; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptide Fragments; Teriparatide | 1992 |